High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)

Francesca R. Mauro, Stefano Molica, Stefano Soddu, Fiorella Ilariucci, Marta Coscia, Francesco Zaja, Emanuele Angelucci, Francesca Re, Anna Marina Liberati, Alessandra Tedeschi, Gianluigi Reda, Daniela Pietrasanta, Alessandro Gozzetti, Roberta Battistini, Giovanni Del Poeta, Caterina Musolino, Mauro Nanni, Alfonso Piciocchi, Marco Vignetti, Antonino NeriFrancesco Albano, Antonio Cuneo, Ilaria Del Giudice, Irene Della Starza, Maria Stefania de Propris, Sara Raponi, Anna R. Guarini, Robin Foà

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2671-2674
JournalHaematologica
Volume105
Issue number11
DOIs
Publication statusPublished - May 1 2020

ASJC Scopus subject areas

  • Hematology

Cite this